Jade Biosciences Analyst Price Targets - Benzinga

Jade Biosciences Inc

JBIONASDAQ

Trade with Public

Trade with Public

$21.70

0.351.64%

Last update: Aug 5, 4:00 PM

$21.70

0.351.64%

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Jade Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Jade Biosciences (JBIO).

Price Target Range — 5 Quarters

Analyst Consensus — 6 Analysts

6Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$46Upside to Avg. PT+112.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jun 15, 2026	UBS	Michael Yee	Initiate	Buy	$45
Jun 2, 2026	Wedbush	Laura Chico	PT Raise	Outperform	$34→$45
Jun 1, 2026	BTIG	Julian Harrison	PT Raise	Buy	$39→$74
Jun 1, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$45→$55
May 27, 2026	BTIG	Julian Harrison	Maintained	Buy	$39
May 11, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$23→$32
May 11, 2026	Wedbush	Laura Chico	PT Raise	Outperform	$24→$34
Apr 27, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$35→$45
Mar 25, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$25→$35
Mar 16, 2026	BTIG	Julian Harrison	PT Raise	Buy	$28→$39
Mar 11, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$17→$23
Mar 9, 2026	Wedbush	Laura Chico	Maintained	Outperform	$24
Jan 7, 2026	HC Wainwright & Co.	Arthur He	Initiate	Buy	$25
Nov 25, 2025	Clear Street	Kaveri Pohlman	Initiate	Buy	$25
Nov 18, 2025	Guggenheim	Vamil Divan	PT Raise	Buy	$14→$17
Oct 9, 2025	BTIG	Julian Harrison	Initiate	Buy	$28
Aug 14, 2025	Wedbush	Laura Chico	PT Raise	Outperform	$17→$18
Jun 16, 2025	Guggenheim	Vamil Divan	Upgrade	Neutral→Buy	$14
May 15, 2025	Wedbush	Laura Chico	Maintained	Outperform	$17
May 7, 2025	Wedbush	Laura Chico	Initiate	Outperform	$17

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Initiates Coverage On Jade Biosciences with Buy Rating, Announces Price Target of $45

UBS analyst Michael Yee initiates coverage on Jade Biosciences (NASDAQ:JBIO) with a Buy rating and announces Price Target of $45.

Benzinga Newsdesk

PRO
Wedbush Maintains Outperform on Jade Biosciences, Raises Price Target to $45

Wedbush analyst Laura Chico maintains Jade Biosciences (NASDAQ:JBIO) with a Outperform and raises the price target from $34 to $45.

Benzinga Newsdesk

Why Is Jade Biosciences Stock Trading Lower On Monday?

Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analyst addresses ADA concerns and timeline expectations.

Vandana Singh

PRO
BTIG Maintains Buy on Jade Biosciences, Raises Price Target to $74

BTIG analyst Julian Harrison maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $39 to $74.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Jade Biosciences, Raises Price Target to $55

HC Wainwright & Co. analyst Arthur He maintains Jade Biosciences (NASDAQ:JBIO) with a Buy and raises the price target from $45 to $55.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Jade Biosciences, Maintains $39 Price Target

BTIG analyst Julian Harrison reiterates Jade Biosciences (NASDAQ:JBIO) with a Buy and maintains $39 price target.

Benzinga Newsdesk